Lataa...
Neuroprotective Effects of Amylin Analogues on Alzheimer’s Disease Pathogenesis and Cognition
Type II diabetes (T2D) has been identified as a major risk factor for the development of Alzheimer’s disease (AD). Interestingly, both AD and T2D have similar characteristics including amyloid peptide aggregation, decreased metabolism, and increased oxidative stress and inflammation. Despite their p...
Tallennettuna:
| Julkaisussa: | J Alzheimers Dis |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6537587/ https://ncbi.nlm.nih.gov/pubmed/30282360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-180433 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|